Fluoxetine versus other types of pharmacotherapy for depression
Fluoxetine trailed a few alternatives slightly on effectiveness in this review - what made it the better fit for me over sertraline?
Top of the evidence hierarchy, independently funded. how we score evidence
Caveat on this rating: One review author disclosed speaking honoraria from several drug manufacturers; the review itself had no external funding.
Pooling 171 randomised trials with 24,868 people, fluoxetine was as effective as older tricyclic antidepressants and better tolerated, though slightly less effective than sertraline, mirtazapine, and venlafaxine.
Worth asking
Fluoxetine trailed a few alternatives slightly on effectiveness in this review - what made it the better fit for me over sertraline?
What it is FDA approved for
Read off the label. Trial duration and approval year are shown only where they were recorded — never inferred.
- Major depressive disorder (acute and maintenance treatment)
- Obsessive-compulsive disorder
- Bulimia nervosa (moderate to severe; binge-eating and vomiting behaviors)
- Panic disorder, with or without agoraphobia
- Depressive episodes associated with bipolar I disorder (in combination with olanzapine)
- Treatment-resistant depression (in combination with olanzapine)
Source
Fluoxetine versus other types of pharmacotherapy for depression — Magni LR, et al. (2013)
Top-tier peer-reviewed journal
Read the source: https://doi.org/10.1002/14651858.CD004185.pub3
DOI: 10.1002/14651858.CD004185.pub3
How this was scored
- Study design
- Meta-analysis of randomised trials
- Funding
- No external funding
- Published in
- Top-tier peer-reviewed journal
- Sample size
- 24,868
- Preregistered
- Yes
- Conflicts disclosed
- Yes
- Independent of proponent
- Yes
- Retracted
- No
Read the full scoring rubric, including what it can't tell you.
Published August 19, 2026.
Questions
How strong is the evidence behind this?
Resolv rates this source "gold standard". Top of the evidence hierarchy, independently funded. It scores 100 out of 100 on our published rubric. One caveat travels with that badge: One review author disclosed speaking honoraria from several drug manufacturers; the review itself had no external funding. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
Fluoxetine versus other types of pharmacotherapy for depression — Magni LR, et al. (2013). Published in: Top-tier peer-reviewed journal. DOI: 10.1002/14651858.CD004185.pub3. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: Meta-analysis of randomised trials. Funding: No external funding. The researchers were independent of whoever benefits from the result. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is fluoxetine (Prozac, Sarafem), prozac, sarafem FDA approved?
Yes — FDA approved for Major depressive disorder (acute and maintenance treatment), Obsessive-compulsive disorder, Bulimia nervosa (moderate to severe; binge-eating and vomiting behaviors), Panic disorder, with or without agoraphobia, Depressive episodes associated with bipolar I disorder (in combination with olanzapine), Treatment-resistant depression (in combination with olanzapine). Approval is for a specific indication, not for everything the drug is prescribed for.
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.